21 CFR 556.227
§ 556.227 Eprinomectin.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 556.227, § 556.227 Eprinomectin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87762
- Permanent ID
ys:prov:87762@1- SHA-256
9df30b916274554a2842bd4ea3ecc89f580dc95da7c83fbd466b95484e58f5b0
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Acceptable daily intake (ADI). The ADI for total residue of eprinomectin is 10 µg/kg of body weight per day.
(b) Tolerances. The tolerances for eprinomectin B1a (marker residue) are:
(1) Cattle.
(i) Liver (target tissue): 1.5 ppm.
(ii) Muscle: 100 ppb.
(iii) Milk: 12 ppb.
(2) [Reserved]
(c) Related conditions of use. See §§ 522.814 and 524.814 of this chapter.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.